Patents Assigned to PROSTATYPE GENOMICS AB
  • Patent number: 12060617
    Abstract: The present invention relates to a method for classifying a prostate cancer in a subject, the method comprising the steps of a) determining a gene expression level or gene expression pattern of the genes F3 and IGFBP3 in a sample from the subject and b) classifying the tumor by comparing the gene expression level determined in a) with a reference gene expression of the same genes in reference patients known to have a high risk tumor respectively. In addition the invention relates to a method for determining prognosis of a subject diagnosed with prostate cancer, a method for making a treatment decision for a subject diagnosed with prostate cancer and a solid support or a kit for classifying a tumor in a subject diagnosed with prostate cancer.
    Type: Grant
    Filed: June 18, 2020
    Date of Patent: August 13, 2024
    Assignee: PROSTATYPE GENOMICS AB
    Inventors: Chunde Li, Zhuochun Peng, Lambert Skoog